Federal health regulators will allow GlaxoSmithKline to continue selling Avandia, a controversial diabetes pill, but will restrict access to the once-blockbuster drug because of heart attack risks. More Details
Amgen Inc. is recalling some lots of its blockbuster Epogen and Procrit anemia treatments because the injected drugs may contain glass flakes that could cause blood clots, swelling of veins, immune system reactions and other problems. More Details
No comments:
Post a Comment